Osteocytes: New Kids on the Block for Cancer in Bone Therapy
Cancers · 07.05.2023 · 15 (9) · 2645
DOI: 10.3390/cancers15092645 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 07.05.2023. Verfasst von Aric Anloague und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
The tumor microenvironment plays a central role in the onset and progression of cancer in the bone. Cancer cells, either from tumors originating in the bone or from metastatic cancer cells from other body systems, are located in specialized niches where they interact with different cells of the bone marrow. These interactions transform the bone into an ideal niche for cancer cell migration, proliferation, and survival and cause an imbalance in bone homeostasis that severely affects the integrity of the skeleton. During the last decade, preclinical studies have identified new cellular mechanisms responsible for the dependency between cancer cells and bone cells. In this review, we focus on osteocytes, long-lived cells residing in the mineral matrix that have recently been identified as key players in the spread of cancer in bone. We highlight the most recent discoveries on how osteocytes support tumor growth and promote bone disease. Additionally, we discuss how the reciprocal crosstalk between osteocytes and cancer cells provides the opportunity to develop new therapeutic strategies to treat cancer in the bone.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
- Department of Physiology and Cell Biology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
ORCID-Profile: Jesus Delgado-Calle
Förderung
- NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- NIAMS NIH HHS
- National Institutes of Health
- University of Arkansas for Medical Sciences Musculoskeletal Hub
- Winthrop P. Rockefeller Cancer Institute Seeds of Sciences Award
- Arkansas Breast Cancer Research Program
Zitieren
APA
Anloague, A., & Delgado-Calle, J. (2023). Osteocytes: New Kids on the Block for Cancer in Bone Therapy. Cancers, 15(9), 2645. https://doi.org/10.3390/cancers15092645
Vancouver
Anloague A, Delgado-Calle J. Osteocytes: New Kids on the Block for Cancer in Bone Therapy. Cancers. 2023;15(9):2645. doi:10.3390/cancers15092645
BibTeX
@article{Anloague2023,
author = {Anloague, Aric and Delgado-Calle, Jesus},
title = {Osteocytes: New Kids on the Block for Cancer in Bone Therapy},
journal = {Cancers},
year = {2023},
volume = {15},
number = {9},
pages = {2645},
doi = {10.3390/cancers15092645}
}
EUVIMED